Deficiency of innate and acquired immunity caused by an IKBKB mutation

New England Journal of Medicine

Volumn 369, Issue 26, 2013, Pages 2504-2514

  Pannicke, Ulrich ^a   Baumann, Bernd ^b   Fuchs, Sebastian ^c   Henneke, Philipp ^c   Rensing Ehl, Anne ^c   Rizzi, Marta ^c   Janda, Ales ^c   Hese, Katrin ^c   Schlesier, Michael ^c   Holzmann, Karlheinz ^b   Borte, Stephan ^d,e   Laux, Constanze ^a   Rump, Eva Maria ^a   Rosenberg, Alan ^f   Zelinski, Teresa ^g   Schrezenmeier, Hubert ^a   Wirth, Thomas ^b   Ehl, Stephan ^c   Schroeder, Marlis L ^g   Schwarz, Klaus ^a  

^a German Red Cross Blood Transfusion Service Baden Württemberg Hessen and University Hospital Ulm   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f UNIVERSITY OF SASKATCHEWAN   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; CYTOKINE RECEPTOR; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGENIC AGENT; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

ADAPTIVE IMMUNITY; AGAMMAGLOBULINEMIA; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CASE REPORT; CHILD; CHROMOSOME 8; CLINICAL FEATURE; DISEASE SEVERITY; EXON; FEMALE; GAMMA DELTA T LYMPHOCYTE; GENE DUPLICATION; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; HOMOZYGOTE; HUMAN; HUMAN CELL; HUMAN GENETICS; IKBKB GENE; IMMUNE DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; INFANT; INNATE IMMUNITY; LYMPHOCYTE COUNT; MALE; MYCOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SEVERE COMBINED IMMUNODEFICIENCY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

EID: 84890918243     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1309199     Document Type: Article

References (32)

1. Dvorak CC, Cowan MJ, Logan BR, et al. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the Primary Immune Deficiency Treatment Consortium prospective study 6901. J Clin Immunol 2013 July 12 (Epub ahead of print).
2. Notarangelo LD. Functional T cell immunodeficiencies (with T cells present). Annu Rev Immunol 2013;31:195-225.
3. Israël A. The IKK complex, a central regulator of NF-kappaB activation. Cold Spring Harb Perspect Biol 2010;2(3):a000158.
4. Oeckinghaus A, Ghosh S. The NF-kappaB family of transcription factors and its regulation. Cold Spring Harb Perspect Biol 2009;1(4):a000034.
5. Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-κB signaling pathways. Nat Immunol 2011;12:695-708.
6. Perkins ND. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol 2007;8:49-62.
7. Hayden MS, Ghosh S. Shared principles in NF-kappaB signaling. Cell 2008;132:344-62.
8. Scheidereit C. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription. Oncogene 2006;25:6685-705.
9. Lupino E, Ramondetti C, Piccinini M. IκB kinase β is required for activation of NF-κB and AP-1 in CD3/CD28-stimulated primary CD4(+) T cells. J Immunol 2012;188:2545-55.
10. Picard C, Casanova JL, Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency. Clin Microbiol Rev 2011;24:490-7.
11. Zonana J, Elder ME, Schneider LC, et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000;67:1555-62.
12. Courtois G, Smahi A, Reichenbach J, et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003;112:1108-15.
13. Janssen R, van Wengen A, Hoeve MA, et al. The same IkappaBalpha mutation in two related individuals leads to completely different clinical syndromes. J Exp Med 2004;200:559-68.
14. McDonald DR, Mooster JL, Reddy M, Bawle E, Secord E, Geha RS. Heterozygous N-terminal deletion of IkappaBalpha results in functional nuclear factor kappaB haploinsufficiency, ectodermal dysplasia, and immune deficiency. J Allergy Clin Immunol 2007;120:900-7.
15. Lopez-Granados E, Keenan JE, Kinney MC, et al. A novel mutation in NFKBIA/IKBA results in a degradation-resistant N-truncated protein and is associated with ectodermal dysplasia with immunodeficiency. Hum Mutat 2008;29:861-8.
16. Mooster JL, Cancrini C, Simonetti A, et al. Immune deficiency caused by impaired expression of nuclear factor-kappaB essential modifier (NEMO) because of a mutation in the 5′ untranslated region of the NEMO gene. J Allergy Clin Immunol 2010;126(1):127.e7-132.e7.
17. Jain G, Voogdt C, Tobias A, et al. IκB kinases modulate the activity of the androgen receptor in prostate carcinoma cell lines. Neoplasia 2012;14:178-89.
18. Morbach H, Eichhorn EM, Liese JG, Girschick HJ. Reference values for B cell subpopulations from infancy to adulthood. Clin Exp Immunol 2010;162:271-9.
19. van Gent R, van Tilburg CM, Nibbelke EE, et al. Refined characterization and reference values of the pediatric T- and B-cell compartments. Clin Immunol 2009;133:95-107. [Erratum, Clin Immunol 2010;136:307-8.]
20. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005;5:230-42.
21. Avery DT, Deenick EK, Ma CS, et al. B cell-intrinsic signaling through IL-21 receptor and STAT3 is required for establishing long-lived antibody responses in humans. J Exp Med 2010;207:155-71.
22. Hodgkin PD, Lee JH, Lyons AB. B cell differentiation and isotype switching is related to division cycle number. J Exp Med 1996;184:277-81.
23. Schmidt-Supprian M, Tian J, Ji H, et al. I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion. J Immunol 2004;173:1612-9.
24. Schmidt-Supprian M, Courtois G, Tian J, et al. Mature T cells depend on signaling through the IKK complex. Immunity 2003;19:377-89.
25. Gerondakis S, Banerjee A, Grigoriadis G, et al. NF-κB subunit specificity in hemopoiesis. Immunol Rev 2012;246:272-85.
26. Li ZW, Omori SA, Labuda T, Karin M, Rickert RC. IKK beta is required for peripheral B cell survival and proliferation. J Immunol 2003;170:4630-7.
27. Pasparakis M, Schmidt-Supprian M, Rajewsky K. IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med 2002;196:743-52.
28. Lahtela J, Nousiainen HO, Stefanovic V, et al. Mutant CHUK and severe fetal encasement malformation. N Engl J Med 2010;363:1631-7.
29. Li Q, Van Antwerp D, Mercurio F, Lee KF, Verma IM. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 1999;284:321-5.
30. Tanaka M, Fuentes ME, Yamaguchi K, et al. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999;10:421-9.
31. Schmid JA, Birbach A. IkappaB kinase beta (IKKbeta/IKK2/IKBKB) - a key molecule in signaling to the transcription factor NF-kappaB. Cytokine Growth Factor Rev 2008;19:157-65.
32. Gilmore TD, Herscovitch M. Inhibitors of NF-kappaB signaling: 785 and counting. Oncogene 2006;25:6887-99.